首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Overcoming retinoic acid-resistance of mammary carcinomas by diverting retinoic acid from PPARβ/δ to RAR
【24h】

Overcoming retinoic acid-resistance of mammary carcinomas by diverting retinoic acid from PPARβ/δ to RAR

机译:通过将视黄酸从PPARβ/δ转移至RAR来克服乳腺癌的视黄酸耐药性

获取原文
获取原文并翻译 | 示例
       

摘要

Retinoic acid (RA) displays potent anticarcinogenic activities that are mediated by the nuclear retinoic acid receptors (RARs). However, use of RA in oncology is limited by RA resistance acquired during carcinogenesis. Moreover, in some cancers, RA facili
机译:维甲酸(RA)显示出强大的抗癌活性,这些活性是由核维甲酸受体(RAR)介导的。但是,RA在肿瘤学中的应用受到致癌过程中获得的RA抗性的限制。此外,在某些癌症中,RA facili

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号